[Usefulness of repetitive transcranial magnetic stimulation in psychiatric disorders].

Abstract : Mental disorders represent a concern for the public health because of their prevalence in the general population. Despite progress in psychopharmacology, 20-30 % of the patients suffering of depressive disorders are responding only partially to different pharmacological and psychological therapeutic strategies. Until recently, the therapeutic alternative in refractory depression was the electroconvulsive therapy. New therapeutic approaches should be therefore explored. In October 2008 repetitive transcranial magnetic stimulation was approved as an antidepressive monotherapy by the FDA, opening the way to a routine application of this technique, which will supplement the body of our therapeutic armamentarium for mood disorders. We review this new therapeutic approach, which is rapidly developing for treating depression and schizophrenia.
Type de document :
Article dans une revue
La Revue De Médecine Interne, Elsevier, 2010, 31 (7), pp.508-14. 〈10.1016/j.revmed.2009.08.007〉
Liste complète des métadonnées

Littérature citée [56 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00797860
Contributeur : Olivier David <>
Soumis le : jeudi 7 mars 2013 - 13:49:28
Dernière modification le : vendredi 1 juin 2018 - 14:02:05
Document(s) archivé(s) le : dimanche 2 avril 2017 - 10:02:13

Fichier

 Accès restreint
Fichier visible le : jamais

Connectez-vous pour demander l'accès au fichier

Identifiants

Collections

U836 | UGA

Citation

David Szekely, Mircea Polosan, Isabelle Grimaldi, Claire Buis, Eugénie Lhommée, et al.. [Usefulness of repetitive transcranial magnetic stimulation in psychiatric disorders].. La Revue De Médecine Interne, Elsevier, 2010, 31 (7), pp.508-14. 〈10.1016/j.revmed.2009.08.007〉. 〈inserm-00797860〉

Partager

Métriques

Consultations de la notice

135